Literature DB >> 25395024

Re.: "Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".

Niklas Schmedt1, Laurent Azoulay2, Sabrina Hense1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25395024     DOI： 10.1093/aje/kwu311

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  4 in total

1.  Metformin and Reduced Risk of Cancer in the Hong Kong Diabetes Registry: Real Effect or Immortal Time Bias?

Authors:  Zhi-Jiang Zhang
Journal:  J Gen Intern Med       Date:  2019-04-25       Impact factor: 5.128

2.  Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.

Authors:  Yuan He; Shanshan Tai; Miao Deng; Zhaona Fan; Fan Ping; Lihong He; Chi Zhang; Yulei Huang; Bin Cheng; Juan Xia
Journal:  Cancer Med       Date:  2019-04-25       Impact factor: 4.452

Review 3.  Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview.

Authors:  Md Ashraf-Uz-Zaman; Aditya Bhalerao; Constantinos M Mikelis; Luca Cucullo; Nadezhda A German
Journal:  Cancers (Basel)       Date:  2020-05-17       Impact factor: 6.639

Review 4.  Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer.

Authors:  Haocheng Wang; Xue Yang; Yang Sun; Yanan Li; Ya Dong; Dongfeng Shan; Zhuang Yu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.